[Federal Register Volume 62, Number 53 (Wednesday, March 19, 1997)]
[Notices]
[Page 13169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6920]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that by application dated August 8, 
1996, and relevant written statements of fact received January 8, 1997, 
B.I. Chemical, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 
23805, made application to the Drug Enforcement Administration (DEA) 
for registration as a bulk manufacturer of the basis classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Methadone (9250)...........................  II                         
Methadone-intermediate (9254)..............  II                         
Levo-alphacetylmethadol (LAAM) (9648)......  II                         
------------------------------------------------------------------------

    The firm plans to manufacturer the listed controlled substances in 
bulk for distribution to its parent company for formulation into 
finished pharmaceuticals.
    Any other such applicant and any person who is presently registered 
with DEA to manufacturer such substances may file comments or 
objectives to the issuance of the above application.
    Any such comments or objections may be addressed, in qunituplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than May 19, 1997.

    Dated: February 21, 1997.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-6920 Filed 3-18-97; 8:45 am]
BILLING CODE 4410-09-M